• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于低、中分化甲状腺癌行甲状腺全切术与甲状腺原发手术的持续争论:一项荟萃分析

The Ongoing Debate Regarding Completion Thyroidectomy Versus Primary Thyroid Surgery for Low and Intermediate Differentiated Thyroid Carcinoma: A Meta-Analysis.

作者信息

Mirghani Hyder, Altedlawi Albalawi Ibrahim A

机构信息

Medicine, University of Tabuk, Tabuk, SAU.

Surgical Oncology, University of Tabuk, Tabuk, SAU.

出版信息

Cureus. 2020 Dec 11;12(12):e12033. doi: 10.7759/cureus.12033.

DOI:10.7759/cureus.12033
PMID:33329985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7734888/
Abstract

Lobectomy is increasingly performed for low-risk differentiated thyroid cancer (DTC) and papillary thyroid microcarcinoma (PTMC). However, there is a continuous controversy about completion thyroidectomy (CT) following lobectomy. The current meta-analysis aimed to assess the outcomes of the initial surgical procedure versus CT performed for low/intermediate-risk thyroid carcinoma. Six hundred and sixty-one articles were retrieved, and only 15 full texts fulfilled the inclusion and exclusion criteria. There were 15 studies, including 17,143 patients; twelve were retrospective, two prospective studies, and a controlled trial. Seven articles were from Asia, four from the USA, two from Europe, while two were published in Canada. The studies showed no difference between lobectomy and primary thyroid surgery regarding post-surgery complications. CT was not different from the initial surgical procedure in terms of complications for DTC. The study was limited by the retrospective studies included, the outcomes assessed were not uniform, and significant heterogeneity was observed. Further, well-controlled, more specific trials are needed.

摘要

对于低风险分化型甲状腺癌(DTC)和甲状腺微小乳头状癌(PTMC),肺叶切除术的实施越来越多。然而,肺叶切除术后的甲状腺全切术(CT)一直存在争议。当前的荟萃分析旨在评估针对低/中风险甲状腺癌进行的初始手术与甲状腺全切术的结果。检索到661篇文章,只有15篇全文符合纳入和排除标准。共有15项研究,包括17143例患者;12项为回顾性研究,2项为前瞻性研究,还有1项对照试验。7篇文章来自亚洲,4篇来自美国,2篇来自欧洲,2篇发表于加拿大。研究表明,肺叶切除术和初次甲状腺手术在术后并发症方面没有差异。对于DTC,甲状腺全切术在并发症方面与初始手术没有差异。该研究受到纳入的回顾性研究的限制,评估的结果不一致,并且观察到显著的异质性。此外,需要进行更严格控制、更具针对性的试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7734888/7afd64b6fcc0/cureus-0012-00000012033-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7734888/a1da02683596/cureus-0012-00000012033-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7734888/2916667e660d/cureus-0012-00000012033-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7734888/7afd64b6fcc0/cureus-0012-00000012033-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7734888/a1da02683596/cureus-0012-00000012033-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7734888/2916667e660d/cureus-0012-00000012033-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a9b/7734888/7afd64b6fcc0/cureus-0012-00000012033-i03.jpg

相似文献

1
The Ongoing Debate Regarding Completion Thyroidectomy Versus Primary Thyroid Surgery for Low and Intermediate Differentiated Thyroid Carcinoma: A Meta-Analysis.关于低、中分化甲状腺癌行甲状腺全切术与甲状腺原发手术的持续争论:一项荟萃分析
Cureus. 2020 Dec 11;12(12):e12033. doi: 10.7759/cureus.12033.
2
Radioactive Iodine Following Total Thyroidectomy Is Comparable to Lobectomy in Low/Intermediate-Risk Differentiated Thyroid Carcinoma: A Meta-Analysis.全甲状腺切除术后放射性碘治疗在低/中危分化型甲状腺癌中的效果与甲状腺叶切除术相当:一项荟萃分析。
Cureus. 2020 Dec 28;12(12):e12332. doi: 10.7759/cureus.12332.
3
The Optimal Activity of Radioactive Iodine for Remnant Ablation in Low/Intermediate Risk Differentiated Thyroid Carcinoma: A Continuous Controversy and Meta-Analysis.放射性碘在低/中危分化型甲状腺癌残留灶消融中的最佳活性:持续的争议与荟萃分析
Cureus. 2021 Jan 27;13(1):e12937. doi: 10.7759/cureus.12937.
4
Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?甲状腺微小乳头状癌行甲状腺腺叶切除术:是否需要行甲状腺全切除术?
Int J Surg. 2017 May;41 Suppl 1:S34-S39. doi: 10.1016/j.ijsu.2017.02.012.
5
Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.传统乳头状甲状腺微小癌行甲状腺全切除术与甲状腺叶切除术的比较:单机构8676例患者分析
Surgery. 2017 Feb;161(2):485-492. doi: 10.1016/j.surg.2016.07.037. Epub 2016 Sep 1.
6
A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.在患有甲状腺微小乳头状癌的患者中,行肺叶切除术与甲状腺全切除术的比较:一项回顾性个体风险因素匹配队列研究。
Eur J Endocrinol. 2017 Apr;176(4):371-378. doi: 10.1530/EJE-16-0845. Epub 2017 Jan 15.
7
Treatment efficacy between total thyroidectomy and lobectomy for patients with papillary thyroid microcarcinoma: A systemic review and meta-analysis.甲状腺全切除术与甲状腺叶切除术治疗甲状腺微小乳头状癌的疗效比较:系统评价和荟萃分析。
Eur J Surg Oncol. 2018 Nov;44(11):1679-1684. doi: 10.1016/j.ejso.2018.08.004. Epub 2018 Aug 13.
8
The rising incidence of papillary thyroid microcarcinoma and is completion surgery necessary or not?甲状腺微小乳头状癌发病率上升,是否需要行根治性手术?
Otolaryngol Pol. 2016 Jun 30;70(3):15-9. doi: 10.5604/00306657.1199990.
9
The rising incidence of papillary thyroid microcarcinoma and is completion surgery necessary or not?甲状腺微小乳头状癌发病率上升,是否需要行根治性手术?
Otolaryngol Pol. 2016 Jun 30;70(0):14-8.
10
Completion Thyroidectomy in Differentiated Thyroid Malignancy-A Prospective Analysis.分化型甲状腺癌甲状腺切除术的完成——一项前瞻性分析
Indian J Surg Oncol. 2019 Mar;10(1):130-134. doi: 10.1007/s13193-018-0845-4. Epub 2018 Dec 5.

引用本文的文献

1
Initial versus Staged Thyroidectomy for Differentiated Thyroid Cancer: A Retrospective Multi-Dimensional Cohort Analysis of Effectiveness and Safety.分化型甲状腺癌的初次与分期甲状腺切除术:有效性和安全性的回顾性多维度队列分析
Cancers (Basel). 2024 Jun 18;16(12):2250. doi: 10.3390/cancers16122250.
2
Dynamic risk assessment in patients with differentiated thyroid cancer.分化型甲状腺癌患者的动态风险评估。
Rev Endocr Metab Disord. 2024 Feb;25(1):79-93. doi: 10.1007/s11154-023-09857-7. Epub 2023 Nov 28.

本文引用的文献

1
Volume, outcomes, and quality standards in thyroid surgery: an evidence-based analysis-European Society of Endocrine Surgeons (ESES) positional statement.甲状腺手术的手术量、治疗效果及质量标准:循证分析——欧洲内分泌外科学会(ESES)立场声明
Langenbecks Arch Surg. 2020 Jun;405(4):401-425. doi: 10.1007/s00423-020-01907-x. Epub 2020 Jun 10.
2
The Relationship Between Imaging and Thyroid Cancer Diagnosis and Survival.影像学检查与甲状腺癌的诊断和生存预后的关系。
Oncologist. 2020 Sep;25(9):765-771. doi: 10.1634/theoncologist.2020-0159. Epub 2020 May 5.
3
Total Versus Completion Thyroidectomy: A Multidimensional Evaluation of Long-Term Vocal Alterations.
甲状腺全切除术与甲状腺次全切除术:长期嗓音改变的多维评估。
Ear Nose Throat J. 2021 Sep;100(5_suppl):562S-568S. doi: 10.1177/0145561319886156. Epub 2019 Dec 4.
4
Obesity and risk of differentiated thyroid cancer: A large-scale case-control study.肥胖与分化型甲状腺癌风险:一项大规模病例对照研究。
Clin Endocrinol (Oxf). 2019 Dec;91(6):869-878. doi: 10.1111/cen.14091. Epub 2019 Oct 1.
5
Completion thyroidectomy: A risky undertaking?甲状腺全切除术:一项危险的手术?
Am J Surg. 2019 Oct;218(4):695-699. doi: 10.1016/j.amjsurg.2019.07.014. Epub 2019 Jul 18.
6
Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.老年低危甲状腺癌:全甲状腺切除术/放射性碘治疗占主导地位,但缺乏生存优势。
J Surg Res. 2019 Nov;243:189-197. doi: 10.1016/j.jss.2019.05.029. Epub 2019 Jun 8.
7
Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?对于低风险分化型甲状腺癌,单侧甲状腺切除术是否足够?
World J Nucl Med. 2019 Apr-Jun;18(2):171-175. doi: 10.4103/wjnm.WJNM_70_18.
8
Lobectomy in patients with differentiated thyroid cancer: indications and follow-up.甲状腺癌患者的肺叶切除术:适应证与随访。
Endocr Relat Cancer. 2019 Jul;26(7):R381-R393. doi: 10.1530/ERC-19-0085.
9
Completion thyroidectomy-indications and complications.甲状腺切除术的完成——适应证与并发症
Eur J Surg Oncol. 2019 Jul;45(7):1129-1131. doi: 10.1016/j.ejso.2019.03.028. Epub 2019 Mar 26.
10
Completion Thyroidectomy: Safer than Thought.甲状腺全切除术:比想象中更安全。
Oncol Res Treat. 2018;41(6):386-390. doi: 10.1159/000487083. Epub 2018 May 3.